Cerebral microangiopathy in patients with non-insulin-dependent diabetes mellitus

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 4, 2007, Pages 259-266

  Petrica, Ligia ^a,b   Petrica, Maxim ^a   Munteanu, Mircea ^a   Vlad, Adrian ^a   Bob, Flaviu ^a   Gluhovschi, Cristina ^a   Gluhovschi, Gheorghe ^a   Jianu, Catalin ^a   Schiller, Adalbert ^a   Velciov, Silvia ^a   Trandafirescu, Virginia ^a   Bozdog, Gheorghe ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NONE   (Romania)

Author keywords

Cerebral microangiopathy; Diabetic nephropathy; Doppler ultrasound; Non insulin dependent diabetes mellitus; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FIBRINOGEN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODYNAMICS; HUMAN; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR;

EID: 34548164056     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Almadal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow- up. Arch Intern Med 2004;164:1422-6.
2. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev 2004;20:268-87.
3. Dalai PM, Parab PV. Cerebrovascular disease in type 2 diabetes mellitus. Neurol India 2002;50:380-5.
4. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(Suppl 2):S54-S64.
5. Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004;62:1558-62.
6. Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. Arterial pulsatility as an index of cerebral microangiopathy in diabetes. Stroke 2000;31:1111-5.
7. Lippera S, Gregorio F, Ceravolo MG, Lagalla G, Provinciali L. Diabetic retinopathy and cerebral hemodynamic impairment in type II diabetes. Eur J Ophthalmol 1997;7:156-62.
8. Fulesdi B, Limburg M, Bereczki D, Michels RP, Neuwirth G, Lesemate D, et al. Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 1997;46:1840-5.
9. Nagata K, Sasaki E, Goda K, Yamamoto N, Sugino M, Hanafusa T, et al. Cerebrovascular disease in type 2 diabetic patients without hypertension. Stroke 2003;34:232-3.
10. Lindegaard KF. Indices of pulsatility. In: Newell DW, Aaslid R, editors. Transcranial Doppler. New York: Raven Press Publishers, 1992:67-82.
11. Nakatou T, Nakata K, Nakamura A, Itoshima T. Carotid haemodynamic parameters as risk factors for cerebral infarction in type 2 diabetic patients. Diabet Med 2004;21:223-9.
12. Shen J, Xue Y, Zhang Y, Wang Q. The application of transcranial Doppler in detecting diabetic cerebral macroangiopathy and microangiopathy [Chinese]. Zhonghua Nei Ke Za Zhi 2002;41:172-4.
13. Sugimori H, Ibayashi S, Ooboshi H, Nagao T, Fujii K, Sadoshima S, et al. Age-related changes in intracranial artery velocity measured by transcranial Doppler sonography in normotensive, hypertensive and diabetic patients [Japanese]. Nippon Ronen Igakkai Zasshi 1993;30:610-6.
14. Sugimori H, Ibayashi S, Fujii K, Sadoshima S, Kuwabara Y, Fujishima M. Can transcranial Doppler really detect reduced cerebral perfusion states? Stroke 1995;26:2053-60.
15. Tkac I, Troscak M, Javorsky M, Petrik R, Tomcova M. Increased intracranial arterial resistance in patients with type 2 diabetes mellitus. Wien Klin Wochenschr 2001;113:870-3.
16. Arosio E, Minuz P, Prior M. Endothelial function and the microcirculation in diabetes mellitus. (Italian) Ann Ital Med Int 1999;14:106-13.
17. Zunker P, Schick A, Buschmann HC, Georgiadis D, Nabavi DG, Edelmann M, et al. Hyperinsulinism and cerebral microangiopathy. Stroke 1996;27:219-23.
18. Guerci B, Kearney-Schwartz A, Bohme P, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab 2001;27:425-34.
19. Guerci B, Kearney-Schwartz A, Bohme P, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effect of treatments in type 2 diabetes mellitus. Diabetes Metab 2001;27:436-47.
20. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
21. Guerrero-Romero F, Rodriguez-Moran M. Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. Stroke 1999;30:1787-91.
22. Thomas GN, Lin JW, Lam WW, Tomlinson B, Yeung V, Chan JC, et al. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in type 2 diabetic Chinese patients. Diabetologia 2004;47:1528-34.
23. Gregorio F, Ambrosi F, Carle F, Boemi M, Boscaro M, Ceravolo MG, et al. Microalbuminuria, brain vasomotor reactivity, carotid and kidney arterial flow in type 2 diabetes mellitus. Diabetes Nutr Metab 2004;17:323-30.
24. Fukuhara T, Hida K. Pulsatility index at the cervical internal carotid artery as a parameter of microangiopathy in patients with type 2 diabetes. J Ultrasound Med 2006;25:599-605.
25. Cosentino F, Assenza E. Diabetes and inflammation. Herz 2004;29:749-59.
26. Grau AJ, Buggle F, Becher H, Werle E, Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular disease. Thromb Res 1996;82:245-55.
27. Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 2003;108:2323-8.
28. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 2004;27:889-94.
29. Matsumoto K, Sera Y, Abe Y, Ueki Y, Tominaga T, Miyake S. Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis 2003;169:317-21.